Morgan Stanley logo MS - Morgan Stanley

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 29
HOLD 22
SELL 1
STRONG
SELL
0
| PRICE TARGET: $243.33 DETAILS
HIGH: $255.00
LOW: $235.00
MEDIAN: $240.00
CONSENSUS: $243.33
UPSIDE: 12.93%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 90% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Fair Value Mild
Trading 1.8% below fair value
Current Price $215.47
Bear Case $153.66 28.7% downside ($153.66 - $215.47) / $215.47 = -28.7% ROTCE 14.2% → 1.46x TBV
Fair Value $219.52 1.9% upside ($219.52 - $215.47) / $215.47 = 1.9% ROTCE 19.0% → 2.14x TBV
Bull Case $285.38 32.4% upside ($285.38 - $215.47) / $215.47 = 32.4% ROTCE 21.8% → 2.54x TBV

Adjust Assumptions

19.0%
11.0%

Key Value Driver

ROTCE (19.0%) vs. cost of equity (11.0%)

Implied Market Multiple 3.82x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $243.33 from 52 analysts, using a 35% weight on analyst consensus. That produces an estimated intrinsic value of $219.52 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Dividend-based valuation: $132.07 (36% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly